Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Feb 7

PMID 35127848

Authors

Dan Li

Jiali Nie

Yu Han

Li Ni

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) is the most common arrhythmia attacking 1. 5-2.0% of general population worldwide. It has a significant impact on morbidity and mortality globally and its prevalence increases exponentially with age. Therapies like catheter ablation or conventional antiarrhythmic drugs have not provided effective solution to the recurrence for AF over the past decades. Over 100 genetic loci have been discovered to be associated with AF by Genome-wide association studies (GWAS) but none has led to a therapy. Recently potential involvement of epigenetics (DNA methylation, histone modification, and non-coding RNAs) in the initiation and maintenance of AF has partly emerged as proof-of-concept in the mechanism and management of AF. Here we reviewed the epigenetic features involved in AF pathophysiology and provided an update of their implications in AF therapy.

Citing Articles

Epigenetic regulation on left atrial function and disease recurrence after catheter ablation in atrial fibrillation.

Han M, Jeong J, Kim Y, Yang H, Seo C, Kim Y Clin Epigenetics. 2024; 16(1):183.

PMID: 39696495 PMC: 11657737. DOI: 10.1186/s13148-024-01794-9.

Atrial fibrillation: pathophysiology, genetic and epigenetic mechanisms.

Vinciguerra M, Dobrev D, Nattel S Lancet Reg Health Eur. 2024; 37:100785.

PMID: 38362554 PMC: 10866930. DOI: 10.1016/j.lanepe.2023.100785.

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases.

Wang Y, Hu J, Wu S, Fleishman J, Li Y, Xu Y Signal Transduct Target Ther. 2023; 8(1):449.

PMID: 38072908 PMC: 10711040. DOI: 10.1038/s41392-023-01720-0.

Higher serum tissue inhibitor of metalloproteinase-1 predicts atrial fibrillation recurrence after radiofrequency catheter ablation.

Li H, Sun W, Wang Z, Wang Z, Du X, Chen J Front Cardiovasc Med. 2022; 9:961914.

PMID: 36312240 PMC: 9606231. DOI: 10.3389/fcvm.2022.961914.

Nerve Growth Factor (NGF) as Partaker in the Modulation of UV-Response in Cultured Human Conjunctival Fibroblasts.

Esposito G, Balzamino B, Rocco M, Aloe L, Micera A Int J Mol Sci. 2022; 23(11).

PMID: 35683016 PMC: 9181148. DOI: 10.3390/ijms23116337.

References

Zhu X, Tang X, Chong H, Cao H, Fan F, Pan J . Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases. Front Cardiovasc Med. 2020; 7:597932. PMC: 7714832. DOI: 10.3389/fcvm.2020.597932. View

Shen K, Tu T, Yuan Z, Yi J, Zhou Y, Liao X . DNA methylation dysregulations in valvular atrial fibrillation. Clin Cardiol. 2017; 40(9):686-691. PMC: 6490353. DOI: 10.1002/clc.22715. View

Wijesurendra R, Casadei B . Mechanisms of atrial fibrillation. Heart. 2019; 105(24):1860-1867. DOI: 10.1136/heartjnl-2018-314267. View

Fatima N, Schooley Jr J, Claycomb W, Flagg T . Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes. PLoS One. 2012; 7(7):e41533. PMC: 3402388. DOI: 10.1371/journal.pone.0041533. View

Nielsen J, Thorolfsdottir R, Fritsche L, Zhou W, Skov M, Graham S . Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat Genet. 2018; 50(9):1234-1239. PMC: 6530775. DOI: 10.1038/s41588-018-0171-3. View

Ruan Z, Wang F, Yu Q, Chen G, Zhu L . Integrative analysis of the circRNA-miRNA regulatory network in atrial fibrillation. Sci Rep. 2020; 10(1):20451. PMC: 7687891. DOI: 10.1038/s41598-020-77485-1. View

Beermann J, Piccoli M, Viereck J, Thum T . Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016; 96(4):1297-325. DOI: 10.1152/physrev.00041.2015. View

Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F . MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 2010; 122(23):2378-87. DOI: 10.1161/CIRCULATIONAHA.110.958967. View

Luo X, Pan Z, Shan H, Xiao J, Sun X, Wang N . MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest. 2013; 123(5):1939-51. PMC: 3635715. DOI: 10.1172/JCI62185. View

10.

Zhang P, Sun J, Li W . Genome-wide profiling reveals atrial fibrillation-related circular RNAs in atrial appendages. Gene. 2019; 728:144286. DOI: 10.1016/j.gene.2019.144286. View

11.

Babapoor-Farrokhran S, Gill D, Rasekhi R . The role of long noncoding RNAs in atrial fibrillation. Heart Rhythm. 2020; 17(6):1043-1049. DOI: 10.1016/j.hrthm.2020.01.015. View

12.

Chen Y, Wakili R, Xiao J, Wu C, Luo X, Clauss S . Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling. J Mol Cell Cardiol. 2014; 77:113-24. DOI: 10.1016/j.yjmcc.2014.10.001. View

13.

Kouzarides T . Chromatin modifications and their function. Cell. 2007; 128(4):693-705. DOI: 10.1016/j.cell.2007.02.005. View

14.

Sun Y, Sun Y, Yue S, Wang Y, Lu F . Histone Deacetylase Inhibitors in Cancer Therapy. Curr Top Med Chem. 2018; 18(28):2420-2428. DOI: 10.2174/1568026619666181210152115. View

15.

Lozano-Velasco E, Franco D, Aranega A, Daimi H . Genetics and Epigenetics of Atrial Fibrillation. Int J Mol Sci. 2020; 21(16). PMC: 7460853. DOI: 10.3390/ijms21165717. View

16.

Iwasaki Y, Nishida K, Kato T, Nattel S . Atrial fibrillation pathophysiology: implications for management. Circulation. 2011; 124(20):2264-74. DOI: 10.1161/CIRCULATIONAHA.111.019893. View

17.

Shangguan W, Liang X, Shi W, Liu T, Wang M, Li G . Identification and characterization of circular RNAs in rapid atrial pacing dog atrial tissue. Biochem Biophys Res Commun. 2018; 506(1):1-6. DOI: 10.1016/j.bbrc.2018.05.082. View

18.

Alqahtani A, Choucair K, Ashraf M, Hammouda D, Alloghbi A, Khan T . Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy. Future Sci OA. 2019; 5(3):FSO372. PMC: 6426170. DOI: 10.4155/fsoa-2018-0115. View

19.

Zhang D, Hu X, Henning R, Brundel B . Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2015; 109(4):519-26. DOI: 10.1093/cvr/cvv265. View

20.

Liu F, Levin M, Petrenko N, Lu M, Wang T, Yuan L . Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol. 2008; 45(6):715-23. PMC: 2630487. DOI: 10.1016/j.yjmcc.2008.08.015. View